Literature DB >> 20871619

The role of Src homology 2 containing protein tyrosine phosphatase 2 in vascular smooth muscle cell migration and proliferation.

Machender R Kandadi1, Matthew S Stratton, Jun Ren.   

Abstract

Vascular smooth muscle cells (VSMCs) perform essential smooth muscle contractile and synthetic functions including migration, differentiation and proliferation under physiological and pathological conditions. In response to pathological stimuli, VMSCs undergo phenotypic change resulting in abnormal migration and proliferation, which may contribute to a "pathogenesis-like" atherosclerosis. Intracellular signaling mechanisms governing this phenotypic switch are of great significance not only for better understanding of atherosclerotic plaque formation but also for strategy for pertinent therapeutic remedies. Src Homology 2 Containing Protein Tyrosine Phosphatase 2 (SHP2) is a ubiquitous tyrosine phosphatase containing Src Homology 2 domains which plays major biological functions in response to various growth factors, hormones or cytokines. In particular, SHP2 is implicated in cell signaling pathways controlling cell cycle progression, growth and migration. In this review we will mainly discuss the recent literature demonstrating the role of SHP2 in VSMC migration and proliferation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20871619      PMCID: PMC4012901          DOI: 10.1038/aps.2010.168

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  51 in total

1.  Predominant expression of the src homology 2-containing tyrosine phosphatase protein SHP2 in vascular smooth muscle cells.

Authors:  M Adachi; H Iwaki; M Shindoh; Y Akao; T Hachiya; M Ikeda; Y Hinoda; K Imai
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

Review 2.  Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle.

Authors:  A D Hughes; G F Clunn; J Refson; C Demoliou-Mason
Journal:  Gen Pharmacol       Date:  1996-10

Review 3.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

Authors:  C Schindler; J E Darnell
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

4.  Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras.

Authors:  A M Bennett; T L Tang; S Sugimoto; C T Walsh; B G Neel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

5.  Identification of a putative Syp substrate, the PDGF beta receptor.

Authors:  R A Klinghoffer; A Kazlauskas
Journal:  J Biol Chem       Date:  1995-09-22       Impact factor: 5.157

6.  Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion.

Authors:  D H Yu; C K Qu; O Henegariu; X Lu; G S Feng
Journal:  J Biol Chem       Date:  1998-08-14       Impact factor: 5.157

7.  Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells.

Authors:  R Sarkar; E G Meinberg; J C Stanley; D Gordon; R C Webb
Journal:  Circ Res       Date:  1996-02       Impact factor: 17.367

8.  Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.

Authors:  M B Marrero; V J Venema; H Ju; D C Eaton; R C Venema
Journal:  Am J Physiol       Date:  1998-11

9.  Lysophosphatidic acid-induced association of SHP-2 with SHPS-1: roles of RHO, FAK, and a SRC family kinase.

Authors:  H Takeda; T Matozaki; Y Fujioka; T Takada; T Noguchi; T Yamao; M Tsuda; F Ochi; K Fukunaga; S Narumiya; T Yamamoto; M Kasuga
Journal:  Oncogene       Date:  1998-06-11       Impact factor: 9.867

10.  Focal adhesion kinase is abundant in developing blood vessels and elevation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II.

Authors:  T R Polte; A J Naftilan; S K Hanks
Journal:  J Cell Biochem       Date:  1994-05       Impact factor: 4.429

View more
  5 in total

1.  Frontiers of vascular biology and disease research.

Authors:  Alex F Chen; Chao-shu Tang
Journal:  Acta Pharmacol Sin       Date:  2010-10       Impact factor: 6.150

2.  Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.

Authors:  Jiawei Zheng; Shanshan Huang; Yufang Huang; Li Song; Yin Yin; Wencui Kong; Xiong Chen; Xuenong Ouyang
Journal:  Tumour Biol       Date:  2015-12-23

3.  Gene expression profiles and signaling mechanisms in α2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells.

Authors:  Anna Huhtinen; Vesa Hongisto; Asta Laiho; Eliisa Löyttyniemi; Dirk Pijnenburg; Mika Scheinin
Journal:  BMC Syst Biol       Date:  2017-06-28

4.  SHP2 inhibitor PHPS1 protects against atherosclerosis by inhibiting smooth muscle cell proliferation.

Authors:  Jia Chen; Zhiyong Cao; Jingshu Guan
Journal:  BMC Cardiovasc Disord       Date:  2018-04-27       Impact factor: 2.298

5.  Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.

Authors:  Yusheng Cheng; Min Yu; Jian Xu; Mengyu He; Hong Wang; Hui Kong; Weiping Xie
Journal:  BMC Pulm Med       Date:  2018-08-07       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.